| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis
|
Hung, WT
|
|
2011
|
20 |
13 |
p. 1404-1410
|
article
|
| 2 |
Antiphospholipid antibodies in patients with purported ‘chronic Lyme disease’
|
Greco, TP
|
|
2011
|
20 |
13 |
p. 1372-1377
|
article
|
| 3 |
Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil
|
Svobodova, B
|
|
2011
|
20 |
13 |
p. 1452-1454
|
article
|
| 4 |
Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis
|
Livingston, B
|
|
2011
|
20 |
13 |
p. 1345-1355
|
article
|
| 5 |
Discrepancies in glomerular and tubulointerstitial/vascular immune complex IgG subclasses in lupus nephritis
|
Satoskar, AA
|
|
2011
|
20 |
13 |
p. 1396-1403
|
article
|
| 6 |
Histone modifications and methyl-CpG-binding domain protein levels at the TNFSF7 (CD70) promoter in SLE CD4+ T cells
|
Zhou, Y
|
|
2011
|
20 |
13 |
p. 1365-1371
|
article
|
| 7 |
1H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus
|
Ouyang, X
|
|
2011
|
20 |
13 |
p. 1411-1420
|
article
|
| 8 |
Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome
|
Lozovoy, MAB
|
|
2011
|
20 |
13 |
p. 1356-1364
|
article
|
| 9 |
Primary antiphospholipid antibody syndrome presenting with encephalopathy, psychosis and seizures
|
Taipa, R
|
|
2011
|
20 |
13 |
p. 1433-1435
|
article
|
| 10 |
Repeated brain conventional MRI and SPECT evaluation in systemic lupus erythematosus patients with and without neuropsychiatric involvement: a follow up study
|
Castellino, G
|
|
2011
|
20 |
13 |
p. 1387-1395
|
article
|
| 11 |
Role of reactive intermediates in the immunopathogenesis of the pristane-induced Balb/c model of lupus
|
Minhas, U
|
|
2011
|
20 |
13 |
p. 1421-1425
|
article
|
| 12 |
Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis
|
|
|
2011
|
20 |
13 |
p. 1455
|
article
|
| 13 |
Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis
|
Sato, N
|
|
2011
|
20 |
13 |
p. 1378-1386
|
article
|
| 14 |
Spontaneous coronary artery dissection in the context of positive anticardiolipin antibodies and clinically undiagnosed systemic lupus erythematosus
|
Nisar, MK
|
|
2011
|
20 |
13 |
p. 1436-1438
|
article
|
| 15 |
Stevens–Johnson syndrome in a juvenile systemic lupus erythematosus patient
|
Cavalcante, EG
|
|
2011
|
20 |
13 |
p. 1439-1441
|
article
|
| 16 |
The effects of cyclophosphamide and mycophenolate on end-stage renal disease and death of lupus nephritis
|
Koo, HS
|
|
2011
|
20 |
13 |
p. 1442-1449
|
article
|
| 17 |
The Systemic Lupus International Collaborating Clinics (SLICC) group – It was 20 years ago today
|
Isenberg, DA
|
|
2011
|
20 |
13 |
p. 1426-1432
|
article
|
| 18 |
Two different clinical subsets of lupus hepatitis exist. Mimicking primary autoimmune liver diseases or part of their spectrum?
|
Piga, M
|
|
2011
|
20 |
13 |
p. 1450-1451
|
article
|
Journal description